RS Charts: Morgan Wallen s Dangerous Holds at Number One Despite Racial Slur
Wallen spends sixth week atop the RS 200, tying a chart record set by Taylor Swift
Elias Leight, provided by
FacebookTwitterEmail
Dangerous: The Double Album spent its sixth consecutive week at Number One on the
Rolling StoneTop 200 Albums chart, earning 7,800 sales and more than 95 million streams. Wallen’s six-week run at Number One matched the
RS 200 record set last year by Taylor Swift’s
Folklore.
Dangerous fell steeply for the first time since
TMZreleased a video of Wallen using a racial slur. After the clip hit the internet,
Dangerous earned more than 137,000 album-equivalent units in each of the next two weeks. But on the latest chart, the singer’s weekly total fell to 86,900 units.
RS Charts: Morgan Wallen s Dangerous Number One Again Despite Racial Slur
RS Charts: Morgan Wallen s Dangerous Number One Again Despite Racial Slur
Country singer s music continued to stream and sell even as parts of the music industry removed their support
Elias Leight, provided by
FacebookTwitterEmail
Dangerous: The Double Album spent its fifth consecutive week at Number One on the
Rolling StoneTop 200 Albums chart. Wallen has prevailed the last two weeks even after a video of him using a racial slur emerged on TMZ, causing radio stations to pull his music out of rotation and streaming services to remove his music from prominent playlists.
Comments
Serum institute of India CEO Adar Poonawalla said that they will be selling the first 100 million doses of its COVID vaccine to the central government at a special price of Rs 200 ‘on their request’, he said on 12 January. “After which we will be selling it at Rs 1,000 in private markets,” he told ANI, while adding the first set of doses is meant to support the common man, vulnerable, poor and healthcare workers.
The Pune-based firm has entered into a collaboration with the University of Oxford and AstraZeneca to manufacture the vaccine.
Also Read
A week ago, Poonawalla had made similar claims to AP. He had said that while the first 100 million doses were being sold to the government at Rs 200, the prices would be increased after that. He said the vaccine would be sold at Rs 1,000 per dose and would be delivered to states within seven to ten days of finalising the deal with the concerned state government.
they not only didn t tell the court that what they had been lying on was completely rubbish. they actually started putting in things to bolster this steele report. that s not what i want. the sound we have is s-200. can you play that, please? all right. we don t have that sound. we played it earlier in the show where william barr, the attorney general of the united states, was suggesting that the investigation itself into the russian attack on 2016 was somehow worse than the actual russian attack. you are on the intelligence committee. you have seen the classified information. to what detriment is a statement like that? well, i m familiar with the attorney general s remarks. we had the fbi director appointed by president trump on the job today saying just the opposite yesterday. you had the senate republican intelligence committee saying exactly the opposite.
like in damascus as those air strikes were bearing down. in the early hours of yesterday morning, around 4:30, there was a number of u.s.-led attacks near damascus in different segments and parts of the city. and i essentially awoke to what was about 12 different strikes, consecutively, one after the other. it was pretty terrifying initially. after the situation cleared initially, you had syrian air defenses began to launch s-200 missiles and tracer fire at the sky in an attempt to down some of the rockets coming through but to no avail. the attack continued for about 50 continuous minutes with temporary pauses in between. after different waves targeted different buildings. and what i could gauge initially from the area i m currently located in in western damascus was that three different military sites were targeted after the first wave. one of those was the research